1.
Zhou WX, Fan JH, Ni QW, Liu MK, Peng Z, Xu Y, et al. Strong Signals of Adverse Events in Tyrosine Kinase Inhibitor Therapy for Liver Cancer Treatment. World J Oncol [Internet]. 2026 Jan. 1 [cited 2026 Apr. 14];17(2):223-36. Available from: https://wjon.elmerpub.com/wjon/article/view/2685